Canada markets closed

Celyad Oncology SA (CLYYF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.35800.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
44
0
0
5
Cost of Revenue
44
0
0
0
Gross Profit
0
0
0
5
Operating Expenses
Research Development
10,540
18,928
20,773
21,522
Selling General and Administrative
7,757
10,337
9,665
9,315
Total Operating Expenses
8,803
20,263
26,909
26,220
Operating Income or Loss
-8,803
-20,263
-26,909
-26,215
Interest Expense
91
197
255
434
Total Other Income/Expenses Net
-
-20,422
523
9,228
Income Before Tax
-30,554
-40,870
-26,502
-17,204
Income Tax Expense
65
65
10
0
Income from Continuing Operations
-30,619
-40,935
-26,512
-17,204
Net Income
-30,619
-40,935
-26,512
-17,204
Net Income available to common shareholders
-30,619
-40,935
-26,512
-17,204
Basic EPS
-1.36
-1.81
-1.70
-1.23
Diluted EPS
-1.36
-1.81
-1.70
-1.23
Basic Average Shares
22,558
22,594
15,604
13,942
Diluted Average Shares
22,558
22,594
15,604
13,942